Hainan Shuangcheng Pharmaceut (002693) — Net Asset Momentum
Hainan Shuangcheng Pharmaceut (002693) recorded a net asset momentum of 2.2% as of December 2025, with net assets of CN¥420.53 Million CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 002693 days of operational coverage to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Hainan Shuangcheng Pharmaceut Net Asset Momentum (2009–2025)
This chart tracks Hainan Shuangcheng Pharmaceut's year-over-year net asset growth across 17 annual reporting periods from 2009 to 2025. The most recent momentum reading is +2.2%, with net assets of CN¥420.53 Million CNY as of December 2025. Read Hainan Shuangcheng Pharmaceut (002693) financial obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for Hainan Shuangcheng Pharmaceut (2009–2025)
The table below shows the complete annual net asset history for Hainan Shuangcheng Pharmaceut from 2009 to 2025, covering 17 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Hainan Shuangcheng Pharmaceut (002693) total market value.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥420.53 Million | CN¥825.78 Million | CN¥405.25 Million | ▲ +2.2% |
| 2024 | CN¥411.61 Million | CN¥783.87 Million | CN¥372.26 Million | ▼ -20.5% |
| 2023 | CN¥517.65 Million | CN¥803.25 Million | CN¥285.60 Million | ▼ -10.9% |
| 2022 | CN¥580.94 Million | CN¥911.02 Million | CN¥330.08 Million | ▲ +2.5% |
| 2021 | CN¥566.75 Million | CN¥854.56 Million | CN¥287.80 Million | ▼ -5.3% |
| 2020 | CN¥598.31 Million | CN¥907.68 Million | CN¥309.37 Million | ▼ -11.8% |
| 2019 | CN¥678.26 Million | CN¥950.98 Million | CN¥272.72 Million | ▲ +1.3% |
| 2018 | CN¥669.69 Million | CN¥1.12 Billion | CN¥450.56 Million | ▼ -12.1% |
| 2017 | CN¥761.71 Million | CN¥1.38 Billion | CN¥615.41 Million | ▲ +37.7% |
| 2016 | CN¥553.13 Million | CN¥1.17 Billion | CN¥612.40 Million | ▼ -40.4% |
| 2015 | CN¥927.61 Million | CN¥1.55 Billion | CN¥622.56 Million | ▲ +3.8% |
| 2014 | CN¥893.55 Million | CN¥943.54 Million | CN¥49.99 Million | ▲ +2.6% |
| 2013 | CN¥870.62 Million | CN¥917.04 Million | CN¥46.42 Million | ▲ +2.9% |
| 2012 | CN¥845.85 Million | CN¥886.65 Million | CN¥40.80 Million | ▲ +270.6% |
| 2011 | CN¥228.23 Million | CN¥248.06 Million | CN¥19.83 Million | ▲ +44.6% |
| 2010 | CN¥157.82 Million | CN¥252.73 Million | CN¥94.92 Million | ▲ +102.5% |
| 2009 | CN¥77.95 Million | CN¥97.85 Million | CN¥19.91 Million | — |